Shigeyuki Aoyama

Latest from Shigeyuki Aoyama

Development of Novel Cellulose Based rProtein A Capture Resins for Improved Workflow Effective Mab Purification
Sponsored Content
Development of Novel Cellulose Based rProtein A Capture Resins for Improved Workflow Effective Mab PurificationDevelopment of Novel Cellulose Based rProtein A Capture Resins for Improved Workflow Effective Mab Purification
byNatsuki Okaniwa, Eri Naritaand 5 more
Aug 24, 2018
Development of a Next Generation Cellulose-Based High Capacity rProtein A Capture Resin for High Throughput MAb Purification in Both Batch and
Sponsored Content
Development of a Next Generation Cellulose-Based High Capacity rProtein A Capture Resin for High Throughput MAb Purification in Both Batch and Continuous Purification FormatsDevelopment of a Next Generation Cellulose-Based High Capacity rProtein A Capture Resin for High Throughput MAb Purification in Both Batch and Continuous Purification Formats
byMasami Shiina, Naoki Yamanakaand 2 more
Dec 15, 2017
1 Min Read

All from Shigeyuki Aoyama

A Novel Cellufine Mixed-Mode Resin: Cellufine™ MAX IB for Polishing of Monoclonal Antibodies
Sponsored Content
A Novel Cellufine Mixed-Mode Resin: Cellufine™ MAX IB for Polishing of Monoclonal Antibodies
A Novel Cellufine Mixed-Mode Resin: Cellufine™ MAX IB for Polishing of Monoclonal Antibodies
Aug 10, 2017
byShigeyuki Aoyama
Adsorption Study of Polymer-Modified Cellufine CEX Resin
Sponsored Content
Adsorption Study of Polymer-Modified Cellufine CEX Resin
Adsorption Study of Polymer-Modified Cellufine CEX Resin
Aug 10, 2016
byShigeyuki Aoyama
Adsorption Study of Egg-Derived Influenza Virus with Cellufine Sulfate Affinity Chromatography Media logo in a gray background | Adsorption Study of Egg-Derived Influenza Virus with Cellufine Sulfate Affinity Chromatography Media
Sponsored Content
Adsorption Study of Egg-Derived Influenza Virus with Cellufine Sulfate Affinity Chromatography Media
Adsorption Study of Egg-Derived Influenza Virus with Cellufine Sulfate Affinity Chromatography Media
Aug 18, 2015
byShigeyuki Aoyama
Removal of Antibody Aggregates Using Cellufine MAX GS logo in a gray background | Removal of Antibody Aggregates Using Cellufine MAX GS
Sponsored Content
Removal of Antibody Aggregates Using Cellufine MAX GS
Removal of Antibody Aggregates Using Cellufine MAX GS
Aug 15, 2014
byShigeyuki Aoyama

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024